Barış Kalaycı spoke in Pharmaceutical Trade Marks Group 99th Conference

"According to latest annual report of Pharmaceutical Security Institute, medicines intended for Turkish market were identified in 198 new incidents that were detected in 44 countries located in seven different regions of the world, thus, Turkey is now considered as one of the global suppliers of diverted and counterfeit medicines. Baris Kalayci, chair of our anti-counterfeiting practice, spoke on ""Fighting Counterfeit and Diverted Medicines in and from Turkey"" at Pharmaceutical Trade Marks Group 99th conference in Berlin, Germany. Click below for the presentation document:"